The French health authority has warned 1.6 million women about a low risk of developing meningioma associated with desogestrel-based contraceptives. While the risk increases with the duration of use, it is still considered low compared to other progestogens. Women are advised to consult their doctors if they experience specific neurological symptoms and not to discontinue their contraceptives without medical guidance.